Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
XB

XBIETF / FundState Street(R) SPDR(R) S&P(R) Biotech ETF

$145.28 last close 2026-11-17
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment XBI's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 62% of portfolio weight covered
Fund look-through

State Street(R) SPDR(R) S&P(R) Biotech ETF ETF · SPDR SERIES TRUST

161 holdings · as of 2026-06-30 (4.6 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.

This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 106% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.

NON-COMPLIANT At least 34.88% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 40% turns out to be. Matching more holdings can only raise this share, never lower it.

161 holdings, 112 matched (62% of weight). Portfolio as of 2026-06-30, filed 2026-08-28. Source: SEC Form N-PORT.

10.88% of this portfolio’s income is non-permissible — weighted across holdings, computed over 53% of portfolio weight (81 of 161 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.

All holdings (161)
HoldingStatusWeightEvery methodology, and the debt ratio behind it
State Street Global Advisors UNSCREENED 5.87% no in-house ratios for this holding
Apogee Therapeutics Inc UNSCREENED 1.49% no in-house ratios for this holding
MRNA Moderna Inc NON_COMPLIANT 1.41% AAOIFI1.4% Usmani9.4% Dow Jones Islamic5.5% S&P Shariah4.5% MSCI Islamic9.2% MSCI Islamic M-Series4.5% FTSE Shariah4.4%
TWST Twist Bioscience Corp COMPLIANT 1.41% AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0%
Oruka Therapeutics Inc UNSCREENED 1.38% no in-house ratios for this holding
KYMR Kymera Therapeutics Inc NON_COMPLIANT 1.36% AAOIFI0.8% Usmani4.8% Dow Jones Islamic1.7% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0%
Viking Therapeutics Inc UNSCREENED 1.30% no in-house ratios for this holding
Praxis Precision Medicines Inc UNSCREENED 1.29% no in-house ratios for this holding
Erasca Inc UNSCREENED 1.27% no in-house ratios for this holding
Revolution Medicines Inc UNSCREENED 1.20% no in-house ratios for this holding
RYTM Rhythm Pharmaceuticals Inc NON_COMPLIANT 1.20% AAOIFI1.8% Usmani25.1% Dow Jones Islamic2.0% S&P Shariah2.4% MSCI Islamic25.1% MSCI Islamic M-Series2.4% FTSE Shariah24.3%
CG oncology Inc UNSCREENED 1.20% no in-house ratios for this holding
SELLAS Life Sciences Group Inc UNSCREENED 1.19% no in-house ratios for this holding
Vaxcyte Inc UNSCREENED 1.19% no in-house ratios for this holding
Dianthus Therapeutics Inc UNSCREENED 1.18% no in-house ratios for this holding
CYTK Cytokinetics Inc COMPLIANT 1.18% AAOIFI7.3% Usmani29.6% Dow Jones Islamic7.7% S&P Shariah8.0% MSCI Islamic29.6% MSCI Islamic M-Series8.0% FTSE Shariah22.9%
NTRA Natera Inc COMPLIANT 1.16% AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0%
Scholar Rock Holding Corp UNSCREENED 1.16% no in-house ratios for this holding
Roivant Sciences Ltd UNSCREENED 1.16% no in-house ratios for this holding
MIRM Mirum Pharmaceuticals Inc COMPLIANT 1.16% AAOIFI11.6% Usmani73.0% Dow Jones Islamic20.3% S&P Shariah25.7% MSCI Islamic73.0% MSCI Islamic M-Series25.7% FTSE Shariah71.8%
Cogent Biosciences Inc UNSCREENED 1.14% no in-house ratios for this holding
RARE Ultragenyx Pharmaceutical Inc NON_COMPLIANT 1.14% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
TVTX Travere Therapeutics Inc COMPLIANT 1.13% AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4%
ALKS Alkermes PLC COMPLIANT 1.11% AAOIFI19.9% Usmani35.4% Dow Jones Islamic27.5% S&P Shariah29.8% MSCI Islamic35.4% MSCI Islamic M-Series29.8% FTSE Shariah33.8%
KRYS Krystal Biotech Inc NON_COMPLIANT 1.10% AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
Celcuity Inc UNSCREENED 1.10% no in-house ratios for this holding
Relay Therapeutics Inc UNSCREENED 1.10% no in-house ratios for this holding
Spyre Therapeutics Inc UNSCREENED 1.10% no in-house ratios for this holding
TGTX TG Therapeutics Inc COMPLIANT 1.09% AAOIFI7.7% Usmani47.4% Dow Jones Islamic12.6% S&P Shariah15.3% MSCI Islamic47.4% MSCI Islamic M-Series15.3% FTSE Shariah46.8%
BEAM Beam Therapeutics Inc NON_COMPLIANT 1.08% AAOIFI10.7% Usmani19.2% Dow Jones Islamic9.9% S&P Shariah10.3% MSCI Islamic19.2% MSCI Islamic M-Series10.3% FTSE Shariah7.9%
Insmed Inc UNSCREENED 1.08% no in-house ratios for this holding
PTGX Protagonist Therapeutics Inc NON_COMPLIANT 1.07% AAOIFI0.1% Usmani0.8% Dow Jones Islamic0.2% S&P Shariah0.2% MSCI Islamic0.8% MSCI Islamic M-Series0.2% FTSE Shariah0.0%
ARWR Arrowhead Pharmaceuticals Inc COMPLIANT 1.07% AAOIFI11.9% Usmani46.3% Dow Jones Islamic12.9% S&P Shariah15.5% MSCI Islamic46.3% MSCI Islamic M-Series15.5% FTSE Shariah39.3%
Vera Therapeutics Inc UNSCREENED 1.06% no in-house ratios for this holding
VRTX Vertex Pharmaceuticals Inc COMPLIANT 1.06% AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0%
MDGL Madrigal Pharmaceuticals Inc COMPLIANT 1.06% AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4%
ABBV AbbVie Inc COMPLIANT 1.04% AAOIFI13.9% Usmani48.9% Dow Jones Islamic19.4% S&P Shariah21.1% MSCI Islamic48.9% MSCI Islamic M-Series21.1% FTSE Shariah48.9%
BIIB Biogen Inc COMPLIANT 1.03% AAOIFI19.7% Usmani23.1% Dow Jones Islamic29.8% S&P Shariah27.2% MSCI Islamic23.1% MSCI Islamic M-Series27.2% FTSE Shariah22.7%
PTCT PTC Therapeutics Inc NON_COMPLIANT 1.03% AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2%
HALO Halozyme Therapeutics Inc COMPLIANT 1.03% AAOIFI29.5% Usmani93.6% Dow Jones Islamic38.6% S&P Shariah42.8% MSCI Islamic93.6% MSCI Islamic M-Series42.8% FTSE Shariah93.6%
uniQure NV UNSCREENED 1.03% no in-house ratios for this holding
BBIO Bridgebio Pharma Inc COMPLIANT 1.02% AAOIFI17.4% Usmani122.4% Dow Jones Islamic24.2% S&P Shariah29.2% MSCI Islamic122.4% MSCI Islamic M-Series29.2% FTSE Shariah121.7%
CRSP CRISPR Therapeutics AG NON_COMPLIANT 1.02% AAOIFI19.9% Usmani30.5% Dow Jones Islamic16.6% S&P Shariah16.4% MSCI Islamic30.5% MSCI Islamic M-Series16.4% FTSE Shariah23.0%
IBRX ImmunityBio Inc COMPLIANT 1.02% AAOIFIpass Usmanifail Dow Jones Islamic— S&P Shariah— MSCI Islamicfail MSCI Islamic M-Series— FTSE Shariahfail
Summit Therapeutics Inc UNSCREENED 1.01% no in-house ratios for this holding
IONS Ionis Pharmaceuticals Inc NON_COMPLIANT 1.00% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
INCY Incyte Corp COMPLIANT 1.00% AAOIFI0.0% Usmani0.5% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
AMGN Amgen Inc COMPLIANT 0.99% AAOIFI21.4% Usmani56.2% Dow Jones Islamic31.0% S&P Shariah32.5% MSCI Islamic56.2% MSCI Islamic M-Series32.5% FTSE Shariah56.2%
NBIX Neurocrine Biosciences Inc COMPLIANT 0.97% AAOIFI2.9% Usmani8.6% Dow Jones Islamic3.4% S&P Shariah3.5% MSCI Islamic8.6% MSCI Islamic M-Series3.5% FTSE Shariah0.0%
GILD Gilead Sciences Inc COMPLIANT 0.96% AAOIFI12.6% Usmani51.0% Dow Jones Islamic17.6% S&P Shariah20.4% MSCI Islamic51.0% MSCI Islamic M-Series20.4% FTSE Shariah51.0%
REGN Regeneron Pharmaceuticals Inc COMPLIANT 0.96% AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8%
EXEL Exelixis Inc COMPLIANT 0.96% AAOIFI1.0% Usmani6.5% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic6.5% MSCI Islamic M-Series1.6% FTSE Shariah0.0%
ALNY Alnylam Pharmaceuticals Inc COMPLIANT 0.96% AAOIFI1.1% Usmani3.1% Dow Jones Islamic0.6% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0%
BMRN BioMarin Pharmaceutical Inc NON_COMPLIANT 0.94% AAOIFI37.0% Usmani36.1% Dow Jones Islamic36.6% S&P Shariah32.3% MSCI Islamic36.1% MSCI Islamic M-Series32.3% FTSE Shariah36.1%
ACAD ACADIA Pharmaceuticals Inc COMPLIANT 0.94% AAOIFI2.2% Usmani4.0% Dow Jones Islamic1.9% S&P Shariah2.0% MSCI Islamic4.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
Nuvalent Inc UNSCREENED 0.93% no in-house ratios for this holding
Immunovant Inc UNSCREENED 0.92% no in-house ratios for this holding
UTHR United Therapeutics Corp NON_COMPLIANT 0.92% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
NTLA Intellia Therapeutics Inc NON_COMPLIANT 0.91% AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0%
GRAL GRAIL Inc NON_COMPLIANT 0.91% AAOIFI1.8% Usmani3.1% Dow Jones Islamic3.5% S&P Shariah4.1% MSCI Islamic3.1% MSCI Islamic M-Series4.1% FTSE Shariah0.0%
BCRX BioCryst Pharmaceuticals Inc NON_COMPLIANT 0.89% AAOIFI21.1% Usmani68.8% Dow Jones Islamic21.3% S&P Shariah23.8% MSCI Islamic68.5% MSCI Islamic M-Series23.8% FTSE Shariah66.9%
Catalyst Pharmaceuticals Inc UNSCREENED 0.87% no in-house ratios for this holding
DYN Dyne Therapeutics Inc NON_COMPLIANT 0.86% AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2%
TNGX Tango Therapeutics Inc NON_COMPLIANT 0.84% AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.8% S&P Shariah2.1% MSCI Islamic3.0% MSCI Islamic M-Series2.1% FTSE Shariah0.0%
Denali Therapeutics Inc UNSCREENED 0.83% no in-house ratios for this holding
VCYT Veracyte Inc COMPLIANT 0.82% AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0%
IDYA Ideaya Biosciences Inc NON_COMPLIANT 0.80% AAOIFI1.0% Usmani2.4% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.4% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
RXRX Recursion Pharmaceuticals Inc NON_COMPLIANT 0.76% AAOIFI3.4% Usmani5.5% Dow Jones Islamic7.3% S&P Shariah6.1% MSCI Islamic5.5% MSCI Islamic M-Series6.1% FTSE Shariah1.2%
SRPT Sarepta Therapeutics Inc NON_COMPLIANT 0.75% AAOIFI43.1% Usmani32.8% Dow Jones Islamic21.4% S&P Shariah14.9% MSCI Islamic32.8% MSCI Islamic M-Series14.9% FTSE Shariah26.6%
RCUS Arcus Biosciences Inc COMPLIANT 0.74% AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9%
Syndax Pharmaceuticals Inc UNSCREENED 0.72% no in-house ratios for this holding
ARQT Arcutis Biotherapeutics Inc COMPLIANT 0.71% AAOIFI3.2% Usmani21.9% Dow Jones Islamic4.5% S&P Shariah5.8% MSCI Islamic21.9% MSCI Islamic M-Series5.8% FTSE Shariah20.9%
Mineralys Therapeutics Inc UNSCREENED 0.71% no in-house ratios for this holding
Celldex Therapeutics Inc UNSCREENED 0.70% no in-house ratios for this holding
AGIO Agios Pharmaceuticals Inc NON_COMPLIANT 0.69% AAOIFI1.4% Usmani2.5% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic2.5% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
Viridian Therapeutics Inc UNSCREENED 0.67% no in-house ratios for this holding
NVAX Novavax Inc NON_COMPLIANT 0.66% AAOIFI17.3% Usmani31.1% Dow Jones Islamic21.2% S&P Shariah22.9% MSCI Islamic30.5% MSCI Islamic M-Series22.9% FTSE Shariah30.5%
Disc Medicine Inc UNSCREENED 0.65% no in-house ratios for this holding
ADMA ADMA Biologics Inc COMPLIANT 0.61% AAOIFI6.7% Usmani27.7% Dow Jones Islamic5.7% S&P Shariah6.4% MSCI Islamic27.7% MSCI Islamic M-Series6.4% FTSE Shariah26.7%
IMNM Immunome Inc NON_COMPLIANT 0.59% AAOIFI0.5% Usmani2.3% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic2.3% MSCI Islamic M-Series0.9% FTSE Shariah0.0%
Palvella Therapeutics Inc UNSCREENED 0.58% no in-house ratios for this holding
IOVA Iovance Biotherapeutics Inc COMPLIANT 0.56% AAOIFI1.2% Usmani5.0% Dow Jones Islamic2.9% S&P Shariah2.4% MSCI Islamic5.0% MSCI Islamic M-Series2.4% FTSE Shariah0.0%
ABSI Absci Corp COMPLIANT 0.56% AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
NRIX Nurix Therapeutics Inc NON_COMPLIANT 0.56% AAOIFI2.1% Usmani10.9% Dow Jones Islamic4.1% S&P Shariah5.0% MSCI Islamic10.9% MSCI Islamic M-Series5.0% FTSE Shariah0.0%
Kodiak Sciences Inc UNSCREENED 0.54% no in-house ratios for this holding
Biohaven Ltd UNSCREENED 0.53% no in-house ratios for this holding
VCEL Vericel Corp COMPLIANT 0.49% AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
ANAB AnaptysBio Inc NON_COMPLIANT 0.49% AAOIFI0.9% Usmani4.1% Dow Jones Islamic1.1% S&P Shariah1.3% MSCI Islamic4.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
CAPR Capricor Therapeutics Inc NON_COMPLIANT 0.49% AAOIFI19.1% Usmani27.9% Dow Jones Islamic11.8% S&P Shariah15.6% MSCI Islamic27.9% MSCI Islamic M-Series15.6% FTSE Shariah0.0%
STOK Stoke Therapeutics Inc NON_COMPLIANT 0.48% AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
GLUE Monte Rosa Therapeutics Inc NON_COMPLIANT 0.48% AAOIFI4.6% Usmani5.2% Dow Jones Islamic4.2% S&P Shariah5.4% MSCI Islamic5.2% MSCI Islamic M-Series5.4% FTSE Shariah0.0%
VIR Vir Biotechnology Inc NON_COMPLIANT 0.47% AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0%
PURR Hyperliquid Strategies Inc NON_COMPLIANT 0.46% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
TYRA Tyra Biosciences Inc COMPLIANT 0.41% AAOIFI0.4% Usmani0.8% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.8% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
CRVS Corvus Pharmaceuticals Inc COMPLIANT 0.41% AAOIFI0.1% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
CGEM Cullinan Therapeutics Inc NON_COMPLIANT 0.40% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
PGEN Precigen Inc NON_COMPLIANT 0.38% AAOIFI3.9% Usmani57.7% Dow Jones Islamic9.9% S&P Shariah12.7% MSCI Islamic57.7% MSCI Islamic M-Series12.7% FTSE Shariah55.1%
Inhibrx Biosciences Inc UNSCREENED 0.35% no in-house ratios for this holding
TSHA Taysha Gene Therapies Inc NON_COMPLIANT 0.35% AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9%
ARDX Ardelyx Inc NON_COMPLIANT 0.35% AAOIFI33.0% Usmani43.6% Dow Jones Islamic20.3% S&P Shariah18.8% MSCI Islamic43.6% MSCI Islamic M-Series18.8% FTSE Shariah43.0%
AVTX Avalo Therapeutics Inc NON_COMPLIANT 0.35% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.1% MSCI Islamic0.0% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
MNKD MannKind Corp NON_COMPLIANT 0.34% AAOIFI26.4% Usmani45.8% Dow Jones Islamic23.7% S&P Shariah24.3% MSCI Islamic45.8% MSCI Islamic M-Series24.3% FTSE Shariah44.2%
ANNX Annexon Inc COMPLIANT 0.33% AAOIFI9.8% Usmani29.2% Dow Jones Islamic46.7% S&P Shariah42.5% MSCI Islamic29.2% MSCI Islamic M-Series42.5% FTSE Shariah19.7%
ORIC ORIC Pharmaceuticals Inc COMPLIANT 0.33% AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
ZBIO Zenas Biopharma Inc NON_COMPLIANT 0.32% AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2%
JBIO Jade Biosciences Inc NON_COMPLIANT 0.32% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
KURA Kura Oncology Inc NON_COMPLIANT 0.32% AAOIFI3.6% Usmani4.6% Dow Jones Islamic3.4% S&P Shariah2.6% MSCI Islamic4.6% MSCI Islamic M-Series2.6% FTSE Shariah1.7%
OLMA Olema Pharmaceuticals Inc NON_COMPLIANT 0.32% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
CDNA CareDx Inc COMPLIANT 0.30% AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
BCAX Bicara Therapeutics Inc NON_COMPLIANT 0.30% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0%
VOR Vor BioPharma Inc NON_COMPLIANT 0.30% AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
Xencor Inc UNSCREENED 0.29% no in-house ratios for this holding
AVBP ArriVent Biopharma Inc NON_COMPLIANT 0.28% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
Replimune Group Inc UNSCREENED 0.28% no in-house ratios for this holding
CTMX CytomX Therapeutics Inc NON_COMPLIANT 0.28% AAOIFI1.0% Usmani1.2% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.2% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
JANX Janux Therapeutics Inc NON_COMPLIANT 0.28% AAOIFI1.7% Usmani2.1% Dow Jones Islamic1.4% S&P Shariah1.4% MSCI Islamic2.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0%
SION Sionna Therapeutics Inc NON_COMPLIANT 0.27% AAOIFI5.1% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0%
GERN Geron Corp NON_COMPLIANT 0.26% AAOIFI20.0% Usmani23.0% Dow Jones Islamic11.6% S&P Shariah8.9% MSCI Islamic23.0% MSCI Islamic M-Series8.9% FTSE Shariah22.8%
Solid Biosciences Inc UNSCREENED 0.24% no in-house ratios for this holding
RIGL Rigel Pharmaceuticals Inc COMPLIANT 0.24% AAOIFI5.0% Usmani8.8% Dow Jones Islamic9.0% S&P Shariah11.3% MSCI Islamic8.8% MSCI Islamic M-Series11.3% FTSE Shariah8.6%
ALLO Allogene Therapeutics Inc NON_COMPLIANT 0.24% AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0%
Sana Biotechnology Inc UNSCREENED 0.23% no in-house ratios for this holding
ALT Altimmune Inc NON_COMPLIANT 0.23% AAOIFI11.3% Usmani7.3% Dow Jones Islamic7.7% S&P Shariah7.6% MSCI Islamic7.3% MSCI Islamic M-Series7.6% FTSE Shariah7.1%
RGNX REGENXBIO Inc NON_COMPLIANT 0.22% AAOIFI11.7% Usmani17.8% Dow Jones Islamic14.0% S&P Shariah12.0% MSCI Islamic17.8% MSCI Islamic M-Series12.0% FTSE Shariah0.0%
IRWD Ironwood Pharmaceuticals Inc NON_COMPLIANT 0.22% AAOIFI30.0% Usmani74.1% Dow Jones Islamic45.1% S&P Shariah27.1% MSCI Islamic74.1% MSCI Islamic M-Series27.1% FTSE Shariah70.0%
IMMX Immix Biopharma Inc NON_COMPLIANT 0.20% AAOIFI0.2% Usmani0.3% Dow Jones Islamic0.4% S&P Shariah0.5% MSCI Islamic0.3% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
OCGN Ocugen Inc NON_COMPLIANT 0.20% AAOIFI1.2% Usmani4.5% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic4.5% MSCI Islamic M-Series1.7% FTSE Shariah1.4%
FDMT 4D Molecular Therapeutics Inc NON_COMPLIANT 0.20% AAOIFI6.2% Usmani9.0% Dow Jones Islamic9.4% S&P Shariah6.5% MSCI Islamic9.0% MSCI Islamic M-Series6.5% FTSE Shariah4.6%
CADL Candel Therapeutics Inc NON_COMPLIANT 0.19% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
SVRA Savara Inc NON_COMPLIANT 0.18% AAOIFI3.0% Usmani19.4% Dow Jones Islamic3.7% S&P Shariah4.0% MSCI Islamic19.4% MSCI Islamic M-Series4.0% FTSE Shariah19.4%
PRME Prime Medicine Inc NON_COMPLIANT 0.18% AAOIFI14.3% Usmani51.6% Dow Jones Islamic20.7% S&P Shariah19.0% MSCI Islamic51.6% MSCI Islamic M-Series19.0% FTSE Shariah0.0%
First Tracks Biotherapeutics Inc UNSCREENED 0.17% no in-house ratios for this holding
DMRA Damora Therapeutics Inc NON_COMPLIANT 0.17% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.2% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
SPRY ARS Pharmaceuticals Inc NON_COMPLIANT 0.17% AAOIFI23.3% Usmani38.7% Dow Jones Islamic9.1% S&P Shariah9.8% MSCI Islamic38.7% MSCI Islamic M-Series9.8% FTSE Shariah38.7%
MPLT MapLight Therapeutics Inc NON_COMPLIANT 0.17% AAOIFI0.3% Usmani0.5% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.5% MSCI Islamic M-Series— FTSE Shariah0.0%
ABUS Arbutus Biopharma Corp NON_COMPLIANT 0.16% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
MYGN Myriad Genetics Inc NON_COMPLIANT 0.16% AAOIFI38.6% Usmani34.4% Dow Jones Islamic32.6% S&P Shariah19.0% MSCI Islamic34.4% MSCI Islamic M-Series19.0% FTSE Shariah19.9%
CABA Cabaletta Bio Inc NON_COMPLIANT 0.15% AAOIFI2.0% Usmani6.9% Dow Jones Islamic1.9% S&P Shariah1.3% MSCI Islamic1.4% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
CMPX Compass Therapeutics Inc NON_COMPLIANT 0.14% AAOIFI7.8% Usmani5.3% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic5.3% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
EBS Emergent BioSolutions Inc NON_COMPLIANT 0.13% AAOIFI172.0% Usmani51.6% Dow Jones Islamic118.8% S&P Shariah134.4% MSCI Islamic51.6% MSCI Islamic M-Series134.4% FTSE Shariah51.0%
PRTA Prothena Corp PLC NON_COMPLIANT 0.13% AAOIFI1.4% Usmani2.3% Dow Jones Islamic1.2% S&P Shariah0.8% MSCI Islamic2.3% MSCI Islamic M-Series0.8% FTSE Shariah0.0%
VNDA Vanda Pharmaceuticals Inc NON_COMPLIANT 0.13% AAOIFI6.5% Usmani5.5% Dow Jones Islamic4.9% S&P Shariah5.1% MSCI Islamic3.8% MSCI Islamic M-Series5.1% FTSE Shariah0.0%
CATX Perspective Therapeutics Inc NON_COMPLIANT 0.13% AAOIFI3.3% Usmani1.0% Dow Jones Islamic1.3% S&P Shariah0.9% MSCI Islamic1.0% MSCI Islamic M-Series0.9% FTSE Shariah0.4%
OVID Ovid therapeutics Inc NON_COMPLIANT 0.12% AAOIFI2.6% Usmani5.6% Dow Jones Islamic6.2% S&P Shariah6.6% MSCI Islamic5.6% MSCI Islamic M-Series6.6% FTSE Shariah0.0%
VSTM Verastem Inc NON_COMPLIANT 0.12% AAOIFI6.3% Usmani16.1% Dow Jones Islamic8.5% S&P Shariah10.1% MSCI Islamic16.1% MSCI Islamic M-Series10.1% FTSE Shariah14.8%
MDXG MiMedx Group Inc COMPLIANT 0.11% AAOIFI2.5% Usmani6.1% Dow Jones Islamic1.9% S&P Shariah1.8% MSCI Islamic6.1% MSCI Islamic M-Series1.8% FTSE Shariah6.1%
Lexeo Therapeutics Inc UNSCREENED 0.11% no in-house ratios for this holding
Achieve Life Sciences Inc UNSCREENED 0.08% no in-house ratios for this holding
SGMT Sagimet Biosciences Inc NON_COMPLIANT 0.07% AAOIFI0.3% Usmani0.7% Dow Jones Islamic1.0% S&P Shariah1.1% MSCI Islamic0.7% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
CONTRA METSERA INC UNSCREENED 0.07% no in-house ratios for this holding
BBOT BridgeBio Oncology Therapeutics Inc NON_COMPLIANT 0.06% AAOIFI1.5% Usmani0.7% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
State Street Global Advisors UNSCREENED 0.04% no in-house ratios for this holding
CONTRA AKERO THERAPEUT UNSCREENED 0.01% no in-house ratios for this holding
CONTRA INHIBRX INC UNSCREENED 0.01% no in-house ratios for this holding
CONTRA MIRATI THERAPEU UNSCREENED 0.01% no in-house ratios for this holding
CONTRA VERVE THERAPEUT UNSCREENED 0.01% no in-house ratios for this holding
CONTRA BLUEPRINT MEDIC UNSCREENED 0.00% no in-house ratios for this holding
State Street Global Advisors UNSCREENED 0.00% no in-house ratios for this holding
RNA Atrium Therapeutics Inc NON_COMPLIANT 0.00% AAOIFI0.4% Usmani0.3% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0%
OABI OMNIAB INC NON_COMPLIANT 0.00% AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0%
OABI OMNIAB INC NON_COMPLIANT 0.00% AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0%

The published standards disagree about this fund by 27 points of portfolio weight — 32.4% of it passes AAOIFI, 5.1% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 32.4% ratios fail on 30.0% 43.4% not rated under AAOIFI

111 of 161 listed holdings carry our own per-methodology verdicts (66% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 105 (62% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
MRNA Moderna Inc 1.41%
KYMR Kymera Therapeutics Inc 1.36%
RYTM Rhythm Pharmaceuticals Inc 1.20%
RARE Ultragenyx Pharmaceutical Inc 1.14%
KRYS Krystal Biotech Inc 1.10%
BEAM Beam Therapeutics Inc 1.08%
PTGX Protagonist Therapeutics Inc 1.07%
PTCT PTC Therapeutics Inc 1.03%
CRSP CRISPR Therapeutics AG 1.02%
IONS Ionis Pharmaceuticals Inc 1.00%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 95.7% aligned
VWAPPrice below VWAP ($149.27)
VolumeRelative volume 4.6× the 20-day average
Momentum10-day rate of change -6.3%
Order flowOptions flow bullish (7.9×)

State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Market & analysts
Momentum (10d)
-6.3%
rate of change
SMC grade
C · 55
95.7% aligned
C · 55
SMC grade — 95.7% timeframe alignment
-6.3%
Rate of change (10d)

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for XBI — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding XBI
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $770M 0.1% 2026-09-30
Israel Englander Millennium Management $539M 0.2% 2026-09-30
Jefferies Jefferies Financial Group $263M 1.9% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $160M 0.2% 2026-09-30
Paul Singer Elliott Investment Management $39M 0.1% 2026-09-30
Steven Cohen Point72 Asset Management $34M 0.0% 2026-09-30
Caxton Associates Caxton Associates LLP $6M 0.1% 2026-09-30
Peter Brown Renaissance Technologies $4M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $1M 0.0% 2026-09-30
David Shaw D. E. Shaw & Co. $0M 0.0% 2026-09-30
Ken Fisher Fisher Asset Management $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

169.55155.50141.45127.40113.342025-11-182026-05-202026-11-17

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
137.97
S2
141.73
S1
143.81
PIVOT
147.57
R1
149.65
R2
153.41
R3
155.49

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
145.10 – 167.28
±7.1% from 156.19, made 2026-10-06 · resolves 2026-10-13
STRONG SELL
from 19 indicators
74.1% of our last 15548 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.3% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
2 buy · 0 neutral · 10 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.70NEUTRAL
Stochastic %K (14)11.96BUY
CCI (20)-183.84BUY
Williams %R (14)-88.04BUY
MACD (12,26,9)-0.86SELL
ROC (10)-6.25SELL
Momentum (10)-9.69SELL
EMA (10)150.77SELL
SMA (10)152.09SELL
EMA (20)151.99SELL
SMA (20)152.92SELL
EMA (30)152.61SELL
SMA (30)151.73SELL
EMA (50)153.26SELL
SMA (50)153.57SELL
EMA (100)151.58SELL
SMA (100)155.89SELL
EMA (200)142.51BUY
SMA (200)143.11BUY

About State Street(R) SPDR(R) S&P(R) Biotech ETF

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
⏰ 4H BEARISH 48
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-6.3%
Rate of change (10d)
4.6×
Volume vs its 20-day average
-1.35
MACD (no fresh cross)
$145.11
Volume POC (today)
$144.14 – $145.33
Value area
BULLISH 7.9x
Unusual options flow

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.